The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

Cellular Origins, the Cell and Gene Therapy Catapult, and Resolution Therapeutics have formed a consortium funded by Innovate ...

The Flamma Group, a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late-stage ...

Grand River Aseptic Manufacturing’s Tyler BeVier on strategic partnerships, cutting-edge capacity, and a patient-first ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

Jazz Pharmaceuticals’ Board of Directors has unanimously selected Renee Gala as President and Chief Executive Officer.

The Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer is ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...

Ofichem Group has agreed to acquire Avivia B.V., a company specialized in formulation development based in Nijmegen, the ...

Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.

New appointments to the leadership team also include Stefan Larson as Chair of the Board of Directors and Ingmar Bruns as a ...

The collaboration aims to enable researchers to easily adapt workflows to their applications while improving efficiency and ...